Enveric Biosciences, Inc. develops cannabinoid medicines and combination therapies. It is a patient-centric biotechnology company endeavouring to enhance the lives of those who are adversely affected by the side effects of Cancer Treatments. The firm is testing natural compounds, starting with cannabinoids to provide patients and clinicians with novel prescription medicines to serve these unmet medical needs. The company was founded on February 28, 1994 and is headquartered in Cambridge, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Other
Employees:
5
Frequently Asked Questions
What is Market Cap of Enveric Biosciences Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Enveric Biosciences Inc market cap is $3.15M.
What is the 52-week high for Enveric Biosciences Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Enveric Biosciences Inc 52 week high is $8.33 as of September 13, 2025.
What is the 52-week low for Enveric Biosciences Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Enveric Biosciences Inc 52 week low is $0.85 as of September 13, 2025.
What is Enveric Biosciences Inc stock price today?
Enveric Biosciences Inc stock price today is $0.9699.
What was Enveric Biosciences Inc stock price yesterday?
Enveric Biosciences Inc stock price yesterday was $0.9949.
What is the PE ratio of Enveric Biosciences Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Enveric Biosciences Inc’s P/E ratio is -0.09.
What is the Price-to-Book ratio of Enveric Biosciences Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Enveric Biosciences Inc P/B ratio is 1.3434.
What is the 50-day moving average of Enveric Biosciences Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Enveric Biosciences Inc 50-day moving average is $1.19.
How many employess does Enveric Biosciences Inc has?